ABEO

ABEONA THERAPEUTICS INC.

Healthcare · Biotechnology

$199.76 sample

+2.21 (+1.12%) 1D

Market cap

$1.10T

Price as of

2026-10-04

Latest filing

8-K · 2026-09-08

Alerts

8

Price$199.76 +1.39% 3M daily closessample

201.88191.82

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider buy: Chief Financial Officer
Sep 17INSInsider sell: Chief Executive Officer
Sep 08SECDEF 14A filed
Sep 02INSInsider sell: EVP, Operations
Aug 24SEC8-K filed: material event
Aug 13INSInsider sell: Director
Aug 05INSInsider buy: 10% owner
Jul 31INSInsider sell: General Counsel

Sign up to see the real ABEO record →

Company facts

SEC EDGAR registration

Name: ABEONA THERAPEUTICS INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +9sample, -100 to +100
Reporting currency: USD

Who is positioning in ABEO

sample

Insiders: 32 insider transactions over 90 days, net selling, $139.3M
Congress: 2 members traded over 90 days
Institutions · 13F: 38 funds hold $26.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$50.0B +12.0% y/y

Q4 2024Q3 2026

Inventory$30.1B +7.0% y/y

Q4 2024Q3 2026

Accounts receivable$22.3B +7.8% y/y

Q4 2024Q3 2026

Total debt$59.5B +10.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $634.8B -10.5% 3M
Sample peer B: $648.2B -2.0% 3M
Sample peer C: $726.4B +13.1% 3M
Sample peer D: $622.0B -0.5% 3M
Sample peer E: $598.9B -6.1% 3M